Andrew Hirsch - Apr 12, 2022 Form 4 Insider Report for C4 Therapeutics, Inc. (CCCC)

Role
President & CEO, Director
Signature
/s/ Jolie M. Siegel, Attorney-in-Fact
Stock symbol
CCCC
Transactions as of
Apr 12, 2022
Transactions value $
$84,000
Form type
4
Date filed
4/12/2022, 04:05 PM
Previous filing
Feb 23, 2022
Next filing
May 27, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction CCCC Common Stock Purchase $84 K +10 K $8.40 10 K Apr 12, 2022 Direct